Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (7)

2024

  1. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin

    Frontiers in Cardiovascular Medicine, Vol. 11

2023

  1. Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes

    Transplant Immunology, Vol. 76

2022

  1. Cancer in patients with heart failure: Incidence, risk factors and prognostic impact

    European Journal of Internal Medicine, Vol. 105, pp. 89-96

2021

  1. Determinants of maximal oxygen uptake in patients with heart failure

    ESC Heart Failure, Vol. 8, Núm. 3, pp. 2002-2008

2020

  1. Incidence, risk factors and prognostic impact of cytomegalovirus infection after heart transplantation

    Medicina Clinica, Vol. 154, Núm. 10, pp. 381-387

2013

  1. Mitochondrial DNA haplogroup H as a risk factor for idiopathic dilated cardiomyopathy in Spanish population

    Mitochondrion, Vol. 13, Núm. 4, pp. 263-268

2012

  1. Mitochondrial Haplogroups H and J: Risk and Protective Factors for Ischemic Cardiomyopathy

    PLoS ONE, Vol. 7, Núm. 8